These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9113494)

  • 1. Clinically significant drug interactions with new immunosuppressive agents.
    Mignat C
    Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tacrolimus-based combination therapies.
    Undre NA
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i12-5. PubMed ID: 12738758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients.
    Figueras J; Bernardos A; Prieto M; Gómez M; Rimola A; Ortiz de Urbina J; Cuervas-Mons V; de la Mata M; Dominguez-Granados R
    Transplant Proc; 2002 Aug; 34(5):1511-3. PubMed ID: 12176461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Newer immunosuppressive agents and their place in current practice].
    Matl I
    Cas Lek Cesk; 2000 Aug; 139(15):460-3. PubMed ID: 22666925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New immunosuppressive drugs in transplantation.
    Groth CG; Ohlman S; Gannedahl G; Ericzon BG
    Transplant Proc; 1993 Aug; 25(4):2681-3. PubMed ID: 7689274
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of new immunosuppressive therapies.
    Nevins TE
    Curr Opin Pediatr; 2000 Apr; 12(2):146-50. PubMed ID: 10763765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive regimens of tomorrow.
    Groth CG
    Transplant Proc; 1995 Dec; 27(6):2971-3. PubMed ID: 8539797
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.
    Jeanmart H; Malo O; Carrier M; Nickner C; Desjardins N; Perrault LP
    J Heart Lung Transplant; 2002 Sep; 21(9):990-8. PubMed ID: 12231370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?
    Lam S; Partovi N; Ting LS; Ensom MH
    Ann Pharmacother; 2008 Jul; 42(7):1037-47. PubMed ID: 18594053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive drugs.
    Collier SJ
    Curr Opin Immunol; 1989-1990; 2(6):854-8. PubMed ID: 2484794
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Vella JP; Sayegh MH
    Postgrad Med J; 1997 Jul; 73(861):386-90. PubMed ID: 9338020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.
    Picard N; Prémaud A; Rousseau A; Le Meur Y; Marquet P
    Br J Clin Pharmacol; 2006 Oct; 62(4):477-84. PubMed ID: 16995869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
    del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
    Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
    Ringe B; Braun F; Lorf T; Canelo R; Schütz E; Sattler B; Ramadori G
    Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.
    Yoshida EM; Marotta PJ; Greig PD; Kneteman NM; Marleau D; Cantarovich M; Peltekian KM; Lilly LB; Scudamore CH; Bain VG; Wall WJ; Roy A; Balshaw RF; Barkun JS
    Liver Transpl; 2005 Sep; 11(9):1064-72. PubMed ID: 16123958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.